The Quality of Antimalarials - A Study in Selected African Countries - EDM Research Series No. 030: Tables: Table IV: Number of samples collected and analysed

The Quality of Antimalarials - A Study in Selected African Countries - EDM Research Series No. 030
(2003; 67 pages)

Table of Contents

Authors
Country Research Team Leaders
Laboratory Support
Acknowledgements
Acronyms
Executive summary
1. Background
2. Methodology
	2.1 Analytical methods
		2.1.1 Method for the assay of chloroquine syrup
		2.1.2 Method for the assay of chloroquine tablets
		2.1.3 Method for the assay of sulphadoxine/pyrimethamine tablets
	2.2 Dissolution testing
		2.2.1 Dissolution method for chloroquine tablets
		2.2.2 Dissolution method for sulphadoxine/pyrimethamine tablets
3. Results
4. Discussion
	4.1 Is there a problem?
	4.2 What is the magnitude of the problem?
	4.3 Is the problem limited to a particular distribution level?
	4.4 Is the problem limited to imported or domestic products?
	4.5 Limitations of the methodology
5. Conclusions and recommendations
	5.1 Conclusions
	5.2 Need for further studies
	5.3 Recommendations for further studies
	5.4 Recommendations for quality and bio-equivalence surveillance
References
Tables
	Table I: Combined country results: percentage failure of samples
	Table II: Combined country results: percentage failure of samples at various collection points
	Table III: Percentage failure of samples as per origin (manufacturer)
	Table IV: Number of samples collected and analysed
	Table IVa: Country results from various collection points - Participating country: Gabon
	Table IVb: Country results from various collection points - Participating country: Ghana
	Table IVc: Country results from various collection points - Participating country: Kenya
	Table IVd: Country results from various collection points - Participating country: Mali
	Table IVe: Country results from various collection points - Participating country: Mozambique
	Table IVf: Country results from various collection points - Participating country: Zimbabwe
	Table IVg: Country results from various collection points - Participating country: Sudan
	Table Va: Country results according to origin of manufacturer - Participating country: Gabon
	Table Vb: Country results according to origin of manufacturer - Participating country: Ghana
	Table Vc: Country results according to origin of manufacturer - Participating country: Kenya
	Table Vd: Country results according to origin of manufacturer - Participating country: Mali
	Table Ve: Country results according to origin of manufacturer - Participating country: Mozambique
	Table Vf: Country results according to origin of manufacturer - Participating country: Zimbabwe
Annexes
	ANNEX: 1A
	ANNEX: 1B
	ANNEX: 1C
	ANNEX: 2A
	ANNEX: 2B
	ANNEX: 2C
	ANNEX: 3A
	ANNEX: 3B
	ANNEX: 3C
	ANNEX: 4A
	ANNEX: 4B
	ANNEX: 4C
	ANNEX: 5A
	ANNEX: 5B
	ANNEX: 5C
	ANNEX: 6A
	ANNEX: 6B
	ANNEX: 6C
	ANNEX: 7A
	ANNEX: 7B
	ANNEX: 7C
Other documents in the EDM Research Series
EDM Research Series No. 30

Table IV: Number of samples collected and analysed

Country	No. of samples collected			No. of samples analysed
	CQT*	CQS**	SPT***	CQT	CQS	SPT
Gabon	20	11	24	19	9	24
Ghana	22	22	22	20	21	22
Kenya	13	11	25	11	9	24
Mali	23	16	14	20	6	14
Mozambique	18	12	40	15	12	36
Sudan	20	20	20	20	16	15
Zimbabwe	15	15	26	15	15	22
Totals	131	107	171	120	88	157

*CQT: Chloroquine tablets
**CQS: Chloroquine syrup
***SPT: Sulphadoxine/pyrimethamine tablets